[Preprint] WHO SOLIDARITY trial results published; Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon do not improve outcomes in Covid-19
Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results – medRxiv Commentaries on Twitter Results of the @WHO SOLIDARITY trial: 4 drugs tested in 11,266 patients with COVID in 405 hospitals in 30 countries:– hydroxychloroquine – lopinavir– remdesevir – interferon No clear benefit of any of them on survival. https://t.co/ohtTAFaSnc pic.twitter.com/2fO9E8zs8h — Martin […]
The post [Preprint] WHO SOLIDARITY trial results published; Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon do not improve outcomes in Covid-19 appeared first on Links Medicus.
Cluster randomized trial: Incentive programs for smoking cessation
Incentive programmes for smoking cessation: cluster randomized trial in workplaces in Thailand – The BMJ Commentary: Incentive-based smoking cessation programs could work in hard-to-reach pockets of smokers across the developing world – University of California San Francisco Commentary on Twitter NEW paper @bmj_latest: #RCT of multiple incentive types for #smoking cessation in worksites in […]
The post Cluster randomized trial: Incentive programs for smoking cessation appeared first on Links Medicus.
WHO Global tuberculosis report 2020
Global tuberculosis report 2020 – World Health Organization News release: WHO: Global TB progress at risk – World Health Organization Executive summary: Global tuberculosis report 2020 Commentary: WHO warns of COVID impact on TB services – CIDRAP Commentary on Twitter The ??? has made steady progress in tackling tuberculosis (TB), with a 1⃣4⃣% drop […]
The post WHO Global tuberculosis report 2020 appeared first on Links Medicus.
Coronavirus vaccine: What we know so far – a comprehensive guide by academic experts
Coronavirus vaccine: what we know so far – a comprehensive guide by academic experts – The Conversation
The post Coronavirus vaccine: What we know so far – a comprehensive guide by academic experts appeared first on Links Medicus.
Review: The duration of infectiousness of individuals infected with SARS-CoV-2
The duration of infectiousness of individuals infected with SARS-CoV-2 – Journal of Infection Commentary on Twitter ?NEW Review?#COVID19 pts with mild-to-moderate illness are highly unlikely to be infectious beyond 10 ds from symptom onset , However, limited studies found that Immunocompromised and severe-to-critical patients may be infectious for >10 days https://t.co/hogXvFpPEb pic.twitter.com/fBm5Se4RBf — Antibiotic […]
The post Review: The duration of infectiousness of individuals infected with SARS-CoV-2 appeared first on Links Medicus.
IDSA Position Statement: “Herd immunity” is not an answer to a pandemic
“Herd Immunity” is Not an Answer to a Pandemic – Infectious Diseases Society of America Commentary on Twitter https://t.co/k15V8bMjiK via @IDSAInfo Excellent statement from @IDSAInfo & @HIVMA Presidents of why "herd immunity" is not an answer to a pandemic. These is the professional association representing > 12K specialists in infectious diseases so these are […]
The post IDSA Position Statement: “Herd immunity” is not an answer to a pandemic appeared first on Links Medicus.
Monoclonal antibody trial halted for safety concern
Monoclonal Antibody Trial Halted for Safety Concern – Brief19 Related: Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 ‘cure’ over safety concern – Reuters
The post Monoclonal antibody trial halted for safety concern appeared first on Links Medicus.
Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant
Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant – STAT News Release: Johnson & Johnson Temporarily Pauses All Dosing in Our Janssen COVID-19 Vaccine Candidate Clinical Trials Commentaries: Johnson & Johnson ‘Pauses’ COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment – […]
The post Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant appeared first on Links Medicus.
Non-respiratory presentations of COVID-19, a clinical review
Non-respiratory presentations of COVID-19, a clinical review – The American Journal of Emergency Medicine
The post Non-respiratory presentations of COVID-19, a clinical review appeared first on Links Medicus.
Genomic evidence for reinfection with SARS-CoV-2: A case study
Genomic evidence for reinfection with SARS-CoV-2: a case study – The Lancet Infectious Diseases Commentaries: First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study – Health Policy Watch AND What reinfections mean for COVID-19 – The Lancet Infectious Diseases AND You can get […]
The post Genomic evidence for reinfection with SARS-CoV-2: A case study appeared first on Links Medicus.